Phenobarbital

Product NDC
0603-5166
11-digit product format
006035166
Labeler code
0603
Product ID
0603-5166_f8c5136e-e35c-4425-8d49-b7f92c827b42
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
phenobarbital
Dosage form
TABLET
Route
ORAL
Labeler
Par Health USA, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2003-02-01
Marketing end
2027-02-28
Substance
PHENOBARBITAL
Active strength
32.4 mg/1
DEA schedule
CIV
NDC exclude flag
No
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0603-51660603-5166-02DDiscontinued by firm2026-08-17
excluded packagepackage0603-51660603-5166-16DDiscontinued by firm2026-08-17
excluded packagepackage0603-51660603-5166-20DDiscontinued by firm2026-08-17
excluded packagepackage0603-51660603-5166-22DDiscontinued by firm2026-08-17
excluded packagepackage0603-51660603-5166-32DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source datePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-050603-5166-20d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050603-5166-02d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050603-5166-22d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050603-5166-16d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-260603-5166-20f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260603-5166-02f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260603-5166-22f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260603-5166-16f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-310603-5166-202ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310603-5166-022ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310603-5166-222ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310603-5166-162ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-280603-5166-20a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280603-5166-02a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280603-5166-22a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280603-5166-16a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-210603-5166-20cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210603-5166-02cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210603-5166-22cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210603-5166-16cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-100603-5166-20cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100603-5166-02cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100603-5166-22cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100603-5166-16cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-310603-5166-20302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310603-5166-02302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310603-5166-22302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310603-5166-16302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-200603-5166-20ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200603-5166-02ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200603-5166-22ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200603-5166-16ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100603-5166-200efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100603-5166-020efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100603-5166-220efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100603-5166-160efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-080603-5166-20ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080603-5166-02ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080603-5166-22ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080603-5166-16ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-030603-5166-20367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-030603-5166-02367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-030603-5166-22367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-030603-5166-16367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-090603-5166-20557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-090603-5166-16557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-090603-5166-02557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-090603-5166-22557ba5c1ecfa…9c80585c8c6e…

Additional Listing Data#

Finished product
Yes
Brand name base
Phenobarbital

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PHENOBARBITAL32.4 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
YQE403BP4DInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
198086Internal RxNorm lookup
199164Internal RxNorm lookup
199167Internal RxNorm lookup
199168Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
069b92ce-0061-4724-8c25-08d8596770a2Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e3e67a66-d325-4d80-8f9d-059e736d7b00Product name120230912

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0603-5166-02Phenobarbital90 in 1 BOTTLE, PLASTICTABLET9013
0603-5166-16Phenobarbital30 in 1 BOTTLE, PLASTICTABLET3013
0603-5166-20Phenobarbital60 in 1 BOTTLE, PLASTICTABLET6013
0603-5166-21Phenobarbital100 in 1 BOTTLE, PLASTICTABLET10013
0603-5166-22Phenobarbital120 in 1 BOTTLE, PLASTICTABLET12013
0603-5166-32Phenobarbital1000 in 1 BOTTLE, PLASTICTABLET100013

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0603-5166-02EA - Each0603-516687bbd8c4-23ad-47fa-badf-6bea07ce872d12012-07-24
0603-5166-16EA - Each0603-51661b259f3a-e4b9-4fb8-af3a-b01ca8b0021812012-07-24
0603-5166-20EA - Each0603-5166cd856b5d-8648-4185-b063-44272db9784e12012-07-24
0603-5166-21EA - Each0603-5166e245f4b1-cb03-4ef6-a814-e00c1e0fac2512012-07-24
0603-5166-22EA - Each0603-51662f7ecf33-b8ec-49d1-9bcc-8128836380ac12012-07-24
0603-5166-32EA - Each0603-5166ea92bd10-1646-49ae-9e15-9570b54f28bd12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PHENOBARBITALACTIVE INGREDIENTYQE403BP4DPHENOBARBITAL TABLET [QUALITEST PHARMACEUTICALS]6
PHENOBARBITALACTIVE MOIETYYQE403BP4DPHENOBARBITAL TABLET [QUALITEST PHARMACEUTICALS]6
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPHENOBARBITAL TABLET [QUALITEST PHARMACEUTICALS]6
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XPHENOBARBITAL TABLET [QUALITEST PHARMACEUTICALS]6
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENOBARBITAL TABLET [QUALITEST PHARMACEUTICALS]6
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PHENOBARBITAL TABLET [QUALITEST PHARMACEUTICALS]6
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2PHENOBARBITAL TABLET [QUALITEST PHARMACEUTICALS]6
PHENOBARBITALACTIVE INGREDIENTYQE403BP4DPHENOBARBITAL TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]2
PHENOBARBITALACTIVE MOIETYYQE403BP4DPHENOBARBITAL TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPHENOBARBITAL TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XPHENOBARBITAL TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENOBARBITAL TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PHENOBARBITAL TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]2
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2PHENOBARBITAL TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]2
PHENOBARBITALACTIVE INGREDIENTYQE403BP4DPHENOBARBITAL TABLET [CONTRACT PHARMACY SERVICES-PA]1
PHENOBARBITALACTIVE INGREDIENTYQE403BP4DPHENOBARBITAL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]1
PHENOBARBITALACTIVE MOIETYYQE403BP4DPHENOBARBITAL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]1
PHENOBARBITALACTIVE MOIETYYQE403BP4DPHENOBARBITAL TABLET [CONTRACT PHARMACY SERVICES-PA]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPHENOBARBITAL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPHENOBARBITAL TABLET [CONTRACT PHARMACY SERVICES-PA]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XPHENOBARBITAL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XPHENOBARBITAL TABLET [CONTRACT PHARMACY SERVICES-PA]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENOBARBITAL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENOBARBITAL TABLET [CONTRACT PHARMACY SERVICES-PA]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PHENOBARBITAL TABLET [CONTRACT PHARMACY SERVICES-PA]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PHENOBARBITAL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]1
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2PHENOBARBITAL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]1
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2PHENOBARBITAL TABLET [CONTRACT PHARMACY SERVICES-PA]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0603-5166PHENOBARBITAL TABLET [ENDO USA, INC.]12Current NDC, Legacy NDC, 6 package rows20240913_069b92ce-0061-4724-8c25-08d8596770a2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PhenobarbitalPHENOBARBITALPar Health USA, LLC069b92ce-0061-4724-8c25-08d8596770a22024-08-20Warnings, Adverse reactionsExact identifier
ndc (product): 0603-5166

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
198086PHENobarbital 16.2 MG Oral TabletPSN069b92ce-0061-4724-8c25-08d8596770a213
199167PHENobarbital 32.4 MG Oral TabletPSN069b92ce-0061-4724-8c25-08d8596770a213
199168PHENobarbital 64.8 MG Oral TabletPSN069b92ce-0061-4724-8c25-08d8596770a213
199164PHENobarbital 97.2 MG Oral TabletPSN069b92ce-0061-4724-8c25-08d8596770a213
198086phenobarbital 16.2 MG Oral TabletSCD069b92ce-0061-4724-8c25-08d8596770a213
199167phenobarbital 32.4 MG Oral TabletSCD069b92ce-0061-4724-8c25-08d8596770a213
199168phenobarbital 64.8 MG Oral TabletSCD069b92ce-0061-4724-8c25-08d8596770a213
199164phenobarbital 97.2 MG Oral TabletSCD069b92ce-0061-4724-8c25-08d8596770a213
199167PHENobarbital 32.4 MG Oral TabletPSNe024b80b-c22f-44bc-b273-f9398f840ed012
199167phenobarbital 32.4 MG Oral TabletSCDe024b80b-c22f-44bc-b273-f9398f840ed012
199167PHENobarbital 32.4 MG Oral TabletPSNe8e1b3d7-0272-4278-b2a3-1d10dbeb0a5a3
199167PHENobarbital 32.4 MG Oral TabletPSNe1756186-6b8c-4965-bfa7-9d5fad3421ab3
199168PHENobarbital 64.8 MG Oral TabletPSNe8e1b3d7-0272-4278-b2a3-1d10dbeb0a5a3
199167phenobarbital 32.4 MG Oral TabletSCDe1756186-6b8c-4965-bfa7-9d5fad3421ab3
199167phenobarbital 32.4 MG Oral TabletSCDe8e1b3d7-0272-4278-b2a3-1d10dbeb0a5a3
199168phenobarbital 64.8 MG Oral TabletSCDe8e1b3d7-0272-4278-b2a3-1d10dbeb0a5a3
199167PHENobarbital 32.4 MG Oral TabletPSNb07a9069-791b-4584-897c-873b8570b83e1
199167phenobarbital 32.4 MG Oral TabletSCDb07a9069-791b-4584-897c-873b8570b83e1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0603-5166-020060351660290 in 1 BOTTLE, PLASTICHistorical
0603-5166-160060351661630 in 1 BOTTLE, PLASTICHistorical
0603-5166-200060351662060 in 1 BOTTLE, PLASTICHistorical
0603-5166-2100603516621100 TABLET in 1 BOTTLE, PLASTIC (0603-5166-21) 100 tablet2003-02-012027-02-28NoNoCurrent
0603-5166-2200603516622120 in 1 BOTTLE, PLASTICHistorical
0603-5166-32006035166321000 TABLET in 1 BOTTLE, PLASTIC (0603-5166-32) 1000 tablet2003-02-012026-05-31NoNoCurrent